8-K/A filed September 13, 2023, 7:59 PM ET ticker LENZ CIK 0001815776

leadership confidence high sentiment neutral materiality 0.60

Graphite Bio amends CEO Josh Lehrer's separation agreement with consulting and equity acceleration terms

LENZ Therapeutics, Inc.

Separation agreement dated Sept 7, 2023 provides Tier 1 severance benefits under Executive Severance Plan.
Lehrer to serve as consultant for up to 12 months or until a Strategic Transaction closes.
Equity awards continue vesting during consulting; acceleration if Strategic Transaction within 6 months.
If Strategic Transaction within 3 months, Lehrer receives enhanced benefits as if termination during Change in Control.
Strategic Transaction defined broadly: merger, sale, reverse merger, or Sale Event under 2021 Stock Plan.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Josh Lehrer

President, Chief Executive Officer

LENZ · LENZ Therapeutics, Inc.

Effective: 2023-08-21
Filed: September 13, 2023, 7:59 PM ET

effective as of August 21, 2023 (the “Termination Date”), Josh Lehrer, M.D., the former President, Chief Executive Officer and member of the Board of Directors of Graphite Bio, Inc. (the “Company”), separated from his employment and all officer and director positions with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Josh Lehrer departed as President, Chief Executive Officer at LENZ Therapeutics, Inc..

Action: separated
Role: President, Chief Executive Officer

Exact text from the filing

effective as of August 21, 2023 (the “Termination Date”), Josh Lehrer, M.D., the former President, Chief Executive Officer and member of the Board of Directors of Graphite Bio, Inc. (the “Company”), separated from his employment and all officer and director positions with the Company.

View on SEC.gov

LENZ Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-047925

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.